<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02766283</url>
  </required_header>
  <id_info>
    <org_study_id>18614</org_study_id>
    <nct_id>NCT02766283</nct_id>
  </id_info>
  <brief_title>Observational Study on Hypothyroidism in Young Children Following Iodine Contrast Exposure</brief_title>
  <official_title>Observational Study on Hypothyroidism in Young Children Following Iodine Contrast Exposure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bayer</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Bayer</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To investigate the incidence of detected hypothyroidism after iodinated contrast exposure in
      pediatric patients from birth to 3 years of age (inclusive) in a routine clinical practice
      setting.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 30, 2016</start_date>
  <completion_date type="Actual">August 30, 2016</completion_date>
  <primary_completion_date type="Actual">August 30, 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Pediatric Patients With Detected Hypothyroidism After Iodinated Contrast Exposure in a Routine Clinical Practice Setting</measure>
    <time_frame>Up to one year after iodinated contrast material (ICM) exposure (828 person years)</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Baseline Characteristics (Sex) of the Cases With Hypothyroidism and of the Rest of the Cohort</measure>
    <time_frame>Up to one year after ICM exposure (828 person years)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Baseline Characteristics (Age) of the Cases With Hypothyroidism and of the Rest of the Cohort</measure>
    <time_frame>At first examination</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Baseline Characteristics (Weight) of the Cases With Hypothyroidism and of the Rest of the Cohort</measure>
    <time_frame>Within a range of Â±360 days of the first examination</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Baseline Characteristics (Comorbidity) of the Cases With Hypothyroidism and of the Rest of the Cohort</measure>
    <time_frame>Prior to first examination</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Baseline Characteristics (Sum of Examinations) in Cases With an Indication of Hypothyroidism and Cases Without</measure>
    <time_frame>Up to one year after ICM exposure (828 person years)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Baseline Characteristics (Type of 1st Examination) in Cases With an Indication of Hypothyroidism and Cases Without</measure>
    <time_frame>Up to one year after ICM exposure (828 person years)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Baseline Characteristics (Type of 2nd Examination) in Cases With an Indication of Hypothyroidism and Cases Without</measure>
    <time_frame>Up to one year after ICM exposure (828 person years)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Baseline Characteristics (Time Between Examinations) in Cases With an Indication of Hypothyroidism and Cases Without</measure>
    <time_frame>Up to one year after ICM exposure (828 person years)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time-relation Between Iodine Contrast Exposure and Diagnosis of Hypothyroidism</measure>
    <time_frame>Up to one year after ICM exposure (828 person years)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The Duration of Hypothyroidism Episode in the &quot;Probable Iodine Induced&quot; Category</measure>
    <time_frame>Up to one year after ICM exposure (828 person years)</time_frame>
    <description>Based on the information collected from the database, the probable longest duration of Hypothyroidism was ascertained for the cases below.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The Duration of Hypothyroidism Episode in the &quot;Probable Iodine Induced&quot; Category</measure>
    <time_frame>Up to one year after ICM exposure (828 person years)</time_frame>
    <description>Based on the information collected from the database, the probable shortest duration of Hypothyroidism was ascertained for the cases below.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">843</enrollment>
  <condition>Hypothyroidism</condition>
  <arm_group>
    <arm_group_label>Iodinated contrast agents</arm_group_label>
    <description>children age 0-3 years (inclusive), who underwent a iodine contrast enhanced radiological examination.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>iodinated contrast agents</intervention_name>
    <description>Intravascular application</description>
    <arm_group_label>Iodinated contrast agents</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Members of Maccabi Health Services database (Israel)
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        - All children age 0-3 years (inclusive) who are identified of having undergone a
        radiological examination with intravascular use of an iodinated contrast agent.(e.g.

        contrast enhanced CT, cardioangiography)

        Exclusion Criteria:

          -  Congenital Hypothyroidism or other forms of preexisting hypothyroidism

          -  Preexisting thyroid hormone replacement therapy less than three months of observation
             before the radiological examination (if greater than three months old)

          -  Less than two weeks follow-up available after the contrast exposure.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>3 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bayer Study Director</last_name>
    <role>Study Director</role>
    <affiliation>Bayer</affiliation>
  </overall_official>
  <location>
    <facility>
      <address>
        <city>Multiple Locations</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <link>
    <url>http://www.fda.gov/cder/drug/DrugSafety/DrugIndex.htm</url>
    <description>Click here and search for drug information provided by the FDA.</description>
  </link>
  <link>
    <url>http://www.fda.gov/medwatch/safety.htm</url>
    <description>Click here and search for information on any recalls, market or product safety alerts by the FDA which might have occurred with this product.</description>
  </link>
  <link>
    <url>http://pharma.bayer.com/en/innovation-partnering/clinical-trials/trial-finder/</url>
    <description>Click here to find results for studies related to Bayer products.</description>
  </link>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 6, 2016</study_first_submitted>
  <study_first_submitted_qc>May 6, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 9, 2016</study_first_posted>
  <results_first_submitted>August 14, 2017</results_first_submitted>
  <results_first_submitted_qc>March 20, 2018</results_first_submitted_qc>
  <results_first_posted type="Estimate">March 26, 2018</results_first_posted>
  <last_update_submitted>March 20, 2018</last_update_submitted>
  <last_update_submitted_qc>March 20, 2018</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 26, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Children</keyword>
  <keyword>Iodinated contrast agents</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypothyroidism</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Iodine</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>This study was a retrospective cohort study, using the data from the years 1998 until 2015 in the database of Maccabi Health Services (Israel).</recruitment_details>
      <pre_assignment_details>Between 1.1.1998 and 31.12.2015, 877 participants were identified. After applying exclusion criteria, 34 participants were excluded from the initial cohort and the final cohort consisted of 843 participants.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Iodine Contrast Agent</title>
          <description>The data used for this retrospective cohort study was from the years 1998 until 2015. The study population consisted of children ages 0-3 (inclusive) who have undergone a radiological examination with an iodinated contrast agent (contrast enhanced CT and cardio-angiography). Follow-up for the outcome (hypothyroidism) was for up to one year after contrast exposure. Incident cases of hypothyroidism were detected by: thyroid-stimulating hormone (TSH) levels, coded diagnosis of hypothyroidism or start of new thyroid replacement therapy.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="843"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="816"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="27"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="27"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Final Cohort</population>
      <group_list>
        <group group_id="B1">
          <title>Iodine Contrast Agent</title>
          <description>The data used for this retrospective cohort study was from the years 1998 until 2015. The study population consisted of children ages 0-3 (inclusive) who have undergone a radiological examination with an iodinated contrast agent (contrast enhanced CT and cardio-angiography). Follow-up for the outcome (hypothyroidism) was for up to one year after contrast exposure. Incident cases of hypothyroidism were detected by: TSH levels, coded diagnosis of hypothyroidism or start of new thyroid replacement therapy.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="843"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="843"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1.06" spread="0.87"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="843"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="382"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="461"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Weight</title>
          <units>Kilograms</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="843"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8.80" spread="3.39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Comorbidity</title>
          <units>Participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Cardio</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="843"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="495"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Diabetes</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="843"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cancer</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="843"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Overweight</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="843"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sum of Examinations</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="843"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>1</title>
                  <measurement_list>
                    <measurement group_id="B1" value="775"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;= 2</title>
                  <measurement_list>
                    <measurement group_id="B1" value="68"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Type of 1st examination</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="843"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Cardio-angiography</title>
                  <measurement_list>
                    <measurement group_id="B1" value="481"/>
                  </measurement_list>
                </category>
                <category>
                  <title>CT</title>
                  <measurement_list>
                    <measurement group_id="B1" value="362"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Type of &gt;=2nd examination</title>
          <population>Participants in final cohort who underwent the 2nd examination</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="68"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Cardio-angiography</title>
                  <measurement_list>
                    <measurement group_id="B1" value="47"/>
                  </measurement_list>
                </category>
                <category>
                  <title>CT</title>
                  <measurement_list>
                    <measurement group_id="B1" value="21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Time between examinations</title>
          <units>Days</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <title>First and second</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="843"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="282.79" spread="252.34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Second and third</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="843"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="208.19" spread="180.01"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Third and fourth</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="843"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="212.00" spread="196.28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Dispenses of hypothyroidism inducing drugs</title>
          <units>Participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Anticonvulsants</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="843"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Amiodarone</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="843"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Pediatric Patients With Detected Hypothyroidism After Iodinated Contrast Exposure in a Routine Clinical Practice Setting</title>
        <time_frame>Up to one year after iodinated contrast material (ICM) exposure (828 person years)</time_frame>
        <population>Final Cohort</population>
        <group_list>
          <group group_id="O1">
            <title>Iodine Contrast Agent</title>
            <description>The data used for this retrospective cohort study was from the years 1998 until 2015. The study population consisted of children ages 0-3 (inclusive) who have undergone a radiological examination with an iodinated contrast agent (contrast enhanced CT and cardio-angiography). Follow-up for the outcome (hypothyroidism) was for up to one year after contrast exposure. Incident cases of hypothyroidism were detected by: TSH levels, coded diagnosis of hypothyroidism or start of new thyroid replacement therapy.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Pediatric Patients With Detected Hypothyroidism After Iodinated Contrast Exposure in a Routine Clinical Practice Setting</title>
          <population>Final Cohort</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="843"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Baseline Characteristics (Sex) of the Cases With Hypothyroidism and of the Rest of the Cohort</title>
        <time_frame>Up to one year after ICM exposure (828 person years)</time_frame>
        <population>Final Cohort</population>
        <group_list>
          <group group_id="O1">
            <title>No Hypothyroidism Indication</title>
            <description>Participants without potential hypothyroidism detected during the one-year follow up period (828 person years)</description>
          </group>
          <group group_id="O2">
            <title>Hypothyroidism Indication</title>
            <description>Participants with potential hypothyroidism detected during the one-year follow up period (828 person years)</description>
          </group>
        </group_list>
        <measure>
          <title>Baseline Characteristics (Sex) of the Cases With Hypothyroidism and of the Rest of the Cohort</title>
          <population>Final Cohort</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="832"/>
                <count group_id="O2" value="11"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="454"/>
                    <measurement group_id="O2" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="378"/>
                    <measurement group_id="O2" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Baseline Characteristics (Age) of the Cases With Hypothyroidism and of the Rest of the Cohort</title>
        <time_frame>At first examination</time_frame>
        <population>Final Cohort</population>
        <group_list>
          <group group_id="O1">
            <title>No Hypothyroidism Indication</title>
            <description>Participants without potential hypothyroidism detected during the one-year follow up period (828 person years)</description>
          </group>
          <group group_id="O2">
            <title>Hypothyroidism Indication</title>
            <description>Participants with potential hypothyroidism detected during the one-year follow up period (828 person years)</description>
          </group>
        </group_list>
        <measure>
          <title>Baseline Characteristics (Age) of the Cases With Hypothyroidism and of the Rest of the Cohort</title>
          <population>Final Cohort</population>
          <units>Years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="832"/>
                <count group_id="O2" value="11"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.07" spread="0.86"/>
                    <measurement group_id="O2" value="0.53" spread="0.96"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Baseline Characteristics (Weight) of the Cases With Hypothyroidism and of the Rest of the Cohort</title>
        <time_frame>Within a range of Â±360 days of the first examination</time_frame>
        <population>Final Cohort</population>
        <group_list>
          <group group_id="O1">
            <title>No Hypothyroidism Indication</title>
            <description>Participants without potential hypothyroidism detected during the one-year follow up period (828 person years)</description>
          </group>
          <group group_id="O2">
            <title>Hypothyroidism Indication</title>
            <description>Participants with potential hypothyroidism detected during the one-year follow up period (828 person years)</description>
          </group>
        </group_list>
        <measure>
          <title>Baseline Characteristics (Weight) of the Cases With Hypothyroidism and of the Rest of the Cohort</title>
          <population>Final Cohort</population>
          <units>Kilograms</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="832"/>
                <count group_id="O2" value="11"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.84" spread="3.37"/>
                    <measurement group_id="O2" value="6.57" spread="3.74"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Baseline Characteristics (Comorbidity) of the Cases With Hypothyroidism and of the Rest of the Cohort</title>
        <time_frame>Prior to first examination</time_frame>
        <population>Final Cohort</population>
        <group_list>
          <group group_id="O1">
            <title>No Hypothyroidism Indication</title>
            <description>Participants without potential hypothyroidism detected during the one-year follow up period (828 person years)</description>
          </group>
          <group group_id="O2">
            <title>Hypothyroidism Indication</title>
            <description>Participants with potential hypothyroidism detected during the one-year follow up period (828 person years)</description>
          </group>
        </group_list>
        <measure>
          <title>Baseline Characteristics (Comorbidity) of the Cases With Hypothyroidism and of the Rest of the Cohort</title>
          <population>Final Cohort</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="832"/>
                <count group_id="O2" value="11"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Cardio</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="485"/>
                    <measurement group_id="O2" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Diabetes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cancer</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Overweight</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Baseline Characteristics (Sum of Examinations) in Cases With an Indication of Hypothyroidism and Cases Without</title>
        <time_frame>Up to one year after ICM exposure (828 person years)</time_frame>
        <population>Final Cohort</population>
        <group_list>
          <group group_id="O1">
            <title>No Hypothyroidism Indication</title>
            <description>Participants without potential hypothyroidism detected during the one-year follow up period (828 person years)</description>
          </group>
          <group group_id="O2">
            <title>Hypothyroidism Indication</title>
            <description>Participants with potential hypothyroidism detected during the one-year follow up period (828 person years)</description>
          </group>
        </group_list>
        <measure>
          <title>Baseline Characteristics (Sum of Examinations) in Cases With an Indication of Hypothyroidism and Cases Without</title>
          <population>Final Cohort</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="832"/>
                <count group_id="O2" value="11"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>1</title>
                  <measurement_list>
                    <measurement group_id="O1" value="765"/>
                    <measurement group_id="O2" value="10"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=2</title>
                  <measurement_list>
                    <measurement group_id="O1" value="67"/>
                    <measurement group_id="O2" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.90</p_value>
            <method>Chi-squared</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Baseline Characteristics (Type of 1st Examination) in Cases With an Indication of Hypothyroidism and Cases Without</title>
        <time_frame>Up to one year after ICM exposure (828 person years)</time_frame>
        <population>Final Cohort</population>
        <group_list>
          <group group_id="O1">
            <title>No Hypothyroidism Indication</title>
            <description>Participants without potential hypothyroidism detected during the one-year follow up period (828 person years)</description>
          </group>
          <group group_id="O2">
            <title>Hypothyroidism Indication</title>
            <description>Participants with potential hypothyroidism detected during the one-year follow up period (828 person years)</description>
          </group>
        </group_list>
        <measure>
          <title>Baseline Characteristics (Type of 1st Examination) in Cases With an Indication of Hypothyroidism and Cases Without</title>
          <population>Final Cohort</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="832"/>
                <count group_id="O2" value="11"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Cardio-angiography</title>
                  <measurement_list>
                    <measurement group_id="O1" value="471"/>
                    <measurement group_id="O2" value="10"/>
                  </measurement_list>
                </category>
                <category>
                  <title>CT</title>
                  <measurement_list>
                    <measurement group_id="O1" value="361"/>
                    <measurement group_id="O2" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.022</p_value>
            <method>Chi-squared</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Baseline Characteristics (Type of 2nd Examination) in Cases With an Indication of Hypothyroidism and Cases Without</title>
        <time_frame>Up to one year after ICM exposure (828 person years)</time_frame>
        <population>Final Cohort</population>
        <group_list>
          <group group_id="O1">
            <title>No Hypothyroidism Indication</title>
            <description>Participants without potential hypothyroidism detected during the one-year follow up period (828 person years)</description>
          </group>
          <group group_id="O2">
            <title>Hypothyroidism Indication</title>
            <description>Participants with potential hypothyroidism detected during the one-year follow up period (828 person years)</description>
          </group>
        </group_list>
        <measure>
          <title>Baseline Characteristics (Type of 2nd Examination) in Cases With an Indication of Hypothyroidism and Cases Without</title>
          <population>Final Cohort</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="832"/>
                <count group_id="O2" value="11"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Cardio-angiography</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="46"/>
                    <measurement group_id="O2" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CT</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Baseline Characteristics (Time Between Examinations) in Cases With an Indication of Hypothyroidism and Cases Without</title>
        <time_frame>Up to one year after ICM exposure (828 person years)</time_frame>
        <population>Final Cohort</population>
        <group_list>
          <group group_id="O1">
            <title>No Hypothyroidism Indication</title>
            <description>Participants without potential hypothyroidism detected during the one-year follow up period (828 person years)</description>
          </group>
          <group group_id="O2">
            <title>Hypothyroidism Indication</title>
            <description>Participants with potential hypothyroidism detected during the one-year follow up period (828 person years)</description>
          </group>
        </group_list>
        <measure>
          <title>Baseline Characteristics (Time Between Examinations) in Cases With an Indication of Hypothyroidism and Cases Without</title>
          <population>Final Cohort</population>
          <units>Days</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="832"/>
                <count group_id="O2" value="11"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>First and second</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="832"/>
                    <count group_id="O2" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="282.72" spread="254.24"/>
                    <measurement group_id="O2" value="288">Only one participants underwent the second examination among the cases with an hypothyroidism indication</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Second and third</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="832"/>
                    <count group_id="O2" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="208.19" spread="180.01"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Third and fourth</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="832"/>
                    <count group_id="O2" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="212.00" spread="196.28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time-relation Between Iodine Contrast Exposure and Diagnosis of Hypothyroidism</title>
        <time_frame>Up to one year after ICM exposure (828 person years)</time_frame>
        <population>Final Cohort</population>
        <group_list>
          <group group_id="O1">
            <title>Final Cohort</title>
            <description>Participants without potential hypothyroidism detected during the one-year follow up period (828 person years)</description>
          </group>
        </group_list>
        <measure>
          <title>Time-relation Between Iodine Contrast Exposure and Diagnosis of Hypothyroidism</title>
          <population>Final Cohort</population>
          <units>Days</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="828"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="76.54" spread="93.05"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>The Duration of Hypothyroidism Episode in the âProbable Iodine Inducedâ Category</title>
        <description>Based on the information collected from the database, the probable longest duration of Hypothyroidism was ascertained for the cases below.</description>
        <time_frame>Up to one year after ICM exposure (828 person years)</time_frame>
        <population>Probable iodine-induced hypothyroidism: (N=8) included all potential cases of hypothyroidism with no other cause than the previous ICM exposure could be identified.</population>
        <group_list>
          <group group_id="O1">
            <title>Probable Iodine-induced Hypothyroidism</title>
            <description>Included all potential cases of hypothyroidism with no other cause than the previous ICM exposure could be identified.</description>
          </group>
        </group_list>
        <measure>
          <title>The Duration of Hypothyroidism Episode in the âProbable Iodine Inducedâ Category</title>
          <description>Based on the information collected from the database, the probable longest duration of Hypothyroidism was ascertained for the cases below.</description>
          <population>Probable iodine-induced hypothyroidism: (N=8) included all potential cases of hypothyroidism with no other cause than the previous ICM exposure could be identified.</population>
          <units>Months</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="8"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Case number 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="NA">Thyroid replacement therapy was dispensed</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Case number 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Case number 6</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="NA">Thyroid replacement therapy was dispensed</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Case number 10</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>The Duration of Hypothyroidism Episode in the âProbable Iodine Inducedâ Category</title>
        <description>Based on the information collected from the database, the probable shortest duration of Hypothyroidism was ascertained for the cases below.</description>
        <time_frame>Up to one year after ICM exposure (828 person years)</time_frame>
        <population>Probable iodine-induced hypothyroidism: (N=8) included all potential cases of hypothyroidism with no other cause than the previous ICM exposure could be identified.</population>
        <group_list>
          <group group_id="O1">
            <title>Probable Iodine-induced Hypothyroidism</title>
            <description>Included all potential cases of hypothyroidism with no other cause than the previous ICM exposure could be identified.</description>
          </group>
        </group_list>
        <measure>
          <title>The Duration of Hypothyroidism Episode in the âProbable Iodine Inducedâ Category</title>
          <description>Based on the information collected from the database, the probable shortest duration of Hypothyroidism was ascertained for the cases below.</description>
          <population>Probable iodine-induced hypothyroidism: (N=8) included all potential cases of hypothyroidism with no other cause than the previous ICM exposure could be identified.</population>
          <units>Months</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="8"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Case number 4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Case number 7</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>The Duration of Hypothyroidism Episode in the âProbable Iodine Inducedâ Category</title>
        <description>Based on the information collected from the database, the probable shortest duration of Hypothyroidism was ascertained for the cases below.</description>
        <time_frame>Up to one year after ICM exposure (828 person years)</time_frame>
        <population>Probable iodine-induced hypothyroidism: (N=8) included all potential cases of hypothyroidism with no other cause than the previous ICM exposure could be identified.</population>
        <group_list>
          <group group_id="O1">
            <title>Probable Iodine-induced Hypothyroidism</title>
            <description>Included all potential cases of hypothyroidism with no other cause than the previous ICM exposure could be identified.</description>
          </group>
        </group_list>
        <measure>
          <title>The Duration of Hypothyroidism Episode in the âProbable Iodine Inducedâ Category</title>
          <description>Based on the information collected from the database, the probable shortest duration of Hypothyroidism was ascertained for the cases below.</description>
          <population>Probable iodine-induced hypothyroidism: (N=8) included all potential cases of hypothyroidism with no other cause than the previous ICM exposure could be identified.</population>
          <units>Days</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="8"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Case number 5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Case number 11</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Up to one year after contrast exposure.</time_frame>
      <desc>This study is a retrospective study using data from the database in Israel. The safety outcome focused on the incidence of hypothyroidism for up to one year after iodine contrast exposure, detected by: TSH levels, coded diagnosis of hypothyroidism or start of new thyroid replacement therapy. Please refer to the result of primary outcome measure.</desc>
      <group_list>
        <group group_id="E1">
          <title>Iodine Contrast Agent</title>
          <description>The data used for this retrospective cohort study was from the years 1998 until 2015. The study population consisted of children ages 0-3 (inclusive) who have undergone a radiological examination with an iodinated contrast agent (contrast enhanced CT and cardio-angiography). Follow-up for the outcome (hypothyroidism) was for up to one year after contrast exposure. Incident cases of hypothyroidism were detected by: TSH levels, coded diagnosis of hypothyroidism or start of new thyroid replacement therapy.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
    </certain_agreements>
    <limitations_and_caveats>This study is a retrospective database analysis study. The safety outcome focused on the incidence of hypothyroidism for up to one year after iodine contrast exposure. Please refer to the result of primary outcome measure for safety evaluation.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Therapeutic Area Head</name_or_title>
      <organization>Bayer</organization>
      <phone>+49 30 300139003</phone>
      <email>clinical-trials-contact@bayer.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

